Stem cells, biomaterials, tissue regeneration, vascular disease, birth defects 

Dr. Wang’s research focuses on developing technologies that combine stem cell engineering and biomaterial engineering to promote tissue regeneration. The Wang Group engineers and develops stem cells, stem cell derivatives and biomaterial-based scaffolds for the treatment of surgical diseases. Ongoing projects include (1) engineering stem cells and stem cell-derived exosomes for tissue regeneration and targeted delivery; (2) developing instructive biomaterial scaffolds for stem cell culture, delivery and recruitment; (3) establishing and using experimental and naturally-occurring disease models to evaluate stem cell and biomaterial products. 

Accepting students per funding availability.